Utilizing nanoparticles would allow drugs to bypass the BBB entirely and avoid the dreaded ABC transporters while simultaneously potentially carrying ABC inhibitors or silencing signals for the ABC transporters to improve drug accumulation in the tumor masses. Here, ABCG2 is linked to neoplasm.